These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 24856614)

  • 61. Synthesis and evaluation of xanomeline analogs--probing the wash-resistant phenomenon at the M1 muscarinic acetylcholine receptor.
    Kane BE; Grant MK; El-Fakahany EE; Ferguson DM
    Bioorg Med Chem; 2008 Feb; 16(3):1376-92. PubMed ID: 17977730
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Polysorbate-80 surface modified nano-stearylamine BQCA conjugate for the management of Alzheimer's disease.
    Chintamaneni PK; Krishnamurthy PT; Pindiprolu SKSS
    RSC Adv; 2021 Jan; 11(10):5325-5334. PubMed ID: 35423107
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Novel M(1) allosteric ligands: a patent review.
    Kuduk SD; Beshore DC
    Expert Opin Ther Pat; 2012 Dec; 22(12):1385-98. PubMed ID: 23092292
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Thiochrome enhances acetylcholine affinity at muscarinic M4 receptors: receptor subtype selectivity via cooperativity rather than affinity.
    Lazareno S; Dolezal V; Popham A; Birdsall NJ
    Mol Pharmacol; 2004 Jan; 65(1):257-66. PubMed ID: 14722259
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Discovery of the first low-shift positive allosteric modulators for the muscarinic M1 receptor.
    Flohr A; Hutter R; Mueller B; Bohnert C; Pellisson M; Schaffhauser H
    Bioorg Med Chem Lett; 2017 Dec; 27(24):5415-5419. PubMed ID: 29146472
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Long-term changes in the muscarinic M1 receptor induced by instantaneous formation of wash-resistant xanomeline-receptor complex.
    De Lorme KC; Grant MK; Noetzel MJ; Polson SB; El-Fakahany EE
    J Pharmacol Exp Ther; 2007 Dec; 323(3):868-76. PubMed ID: 17855477
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pharmacological analysis of the novel mode of interaction between xanomeline and the M1 muscarinic acetylcholine receptor.
    Christopoulos A; Parsons AM; El-Fakahany EE
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1220-8. PubMed ID: 10336509
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Toward activated homology models of the human M1 muscarinic acetylcholine receptor.
    Chin SP; Buckle MJ; Chalmers DK; Yuriev E; Doughty SW
    J Mol Graph Model; 2014 Apr; 49():91-8. PubMed ID: 24631873
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Development of M1 mAChR allosteric and bitopic ligands: prospective therapeutics for the treatment of cognitive deficits.
    Davie BJ; Christopoulos A; Scammells PJ
    ACS Chem Neurosci; 2013 Jul; 4(7):1026-48. PubMed ID: 23659787
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Identification of a methoxynaphthalene scaffold as a core replacement in quinolizidinone amide M(1) positive allosteric modulators.
    Kuduk SD; Di Marco CN; Saffold JR; Ray WJ; Ma L; Wittmann M; Koeplinger KA; Thompson CD; Hartman GD; Bilodeau MT; Beshore DC
    Bioorg Med Chem Lett; 2014 Mar; 24(5):1417-20. PubMed ID: 24485781
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Forebrain Cholinergic Signaling Regulates Innate Immune Responses and Inflammation.
    Lehner KR; Silverman HA; Addorisio ME; Roy A; Al-Onaizi MA; Levine Y; Olofsson PS; Chavan SS; Gros R; Nathanson NM; Al-Abed Y; Metz CN; Prado VF; Prado MAM; Tracey KJ; Pavlov VA
    Front Immunol; 2019; 10():585. PubMed ID: 31024522
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Exploration of the orthosteric/allosteric interface in human M1 muscarinic receptors by bitopic fluorescent ligands.
    Daval SB; Kellenberger E; Bonnet D; Utard V; Galzi JL; Ilien B
    Mol Pharmacol; 2013 Jul; 84(1):71-85. PubMed ID: 23604140
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Chemical lead optimization of a pan G(q) mAChR M(1), M(3), M(5) positive allosteric modulator (PAM) lead. Part I: Development of the first highly selective M(5) PAM.
    Bridges TM; Kennedy JP; Cho HP; Breininger ML; Gentry PR; Hopkins CR; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2010 Jan; 20(2):558-62. PubMed ID: 20004578
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Synthesis and SAR of N-(4-(4-alklylpiperazin-1-yl)phenyl)benzamides as muscarinic acetylcholine receptor subtype 1 (M1) anatgonists.
    Miller NR; Daniels RN; Lee D; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2174-7. PubMed ID: 20202841
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Identification of M1 and M2 muscarinic acetylcholine receptors in the cat carotid body chemosensory system.
    Shirahata M; Hirasawa S; Okumura M; Mendoza JA; Okumura A; Balbir A; Fitzgerald RS
    Neuroscience; 2004; 128(3):635-44. PubMed ID: 15381291
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Characterization of the novel positive allosteric modulator, LY2119620, at the muscarinic M(2) and M(4) receptors.
    Croy CH; Schober DA; Xiao H; Quets A; Christopoulos A; Felder CC
    Mol Pharmacol; 2014 Jul; 86(1):106-15. PubMed ID: 24807965
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Subtype-selective positive cooperative interactions between brucine analogs and acetylcholine at muscarinic receptors: functional studies.
    Birdsall NJ; Farries T; Gharagozloo P; Kobayashi S; Lazareno S; Sugimoto M
    Mol Pharmacol; 1999 Apr; 55(4):778-86. PubMed ID: 10101037
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Pharmacological assessment of m1 muscarinic acetylcholine receptor-gq/11 protein coupling in membranes prepared from postmortem human brain tissue.
    Salah-Uddin H; Thomas DR; Davies CH; Hagan JJ; Wood MD; Watson JM; Challiss RA
    J Pharmacol Exp Ther; 2008 Jun; 325(3):869-74. PubMed ID: 18322150
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Widespread Changes in Positive Allosteric Modulation of the Muscarinic M1 Receptor in Some Participants With Schizophrenia.
    Hopper S; Pavey GM; Gogos A; Dean B
    Int J Neuropsychopharmacol; 2019 Oct; 22(10):640-650. PubMed ID: 31428788
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Novel BQCA- and TBPB-Derived M
    Schramm S; Agnetta L; Bermudez M; Gerwe H; Irmen M; Holze J; Littmann T; Wolber G; Tränkle C; Decker M
    ChemMedChem; 2019 Jul; 14(14):1349-1358. PubMed ID: 31166078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.